LENVATINIB
lenvatinib 4 mg capsule, 30
LENVATINIB (10952K)
10952K
Manner of administration:Oral
Restriction (Streamlined authority code: 17864)
Indication: Locally advanced or metastatic differentiated thyroid cancer
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 17865)
Indication: Locally advanced or metastatic differentiated thyroid cancer
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $2,126.84 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenvima | |||||